Subtle Cognitive Impairments in Patients with Long-Term Cure of Cushing’s Disease
The DOI matches its Crossref record; 40 of the 41 references it cites were found in a registry or an index.
Abstract
CONTEXT AND OBJECTIVE: Active Cushing's disease is associated with cognitive impairments. We hypothesized that previous hypercortisolism in patients with Cushing's disease results in irreversible impairments in cognitive functioning. Therefore, our aim was to assess cognitive functioning after long-term cure of Cushing's disease. DESIGN: Cognitive assessment consisted of 11 tests, which evaluated global cognitive functioning, memory, and executive functioning. PATIENTS AND CONTROL SUBJECTS: We included 74 patients cured of Cushing's disease and 74 controls matched for age, gender, and education. Furthermore, we included 54 patients previously treated for nonfunctioning pituitary macroadenomas (NFMA) and 54 controls matched for age, gender, and education. RESULTS: Compared with NFMA patients, patients cured from Cushing's disease had lower scores on the Mini Mental State Examination (P = 0.001), and on the memory quotient of the Wechsler Memory Scale (P = 0.050). Furthermore, patients cured from Cushing's disease tended to recall fewer words on the imprinting (P = 0.013), immediate recall (P = 0.012), and delayed recall (P = 0.003) trials of the Verbal Learning Test of Rey. On the Rey Complex Figure Test, patients cured from Cushing's disease had lower scores on both trials (P = 0.002 and P = 0.007) compared with NFMA patients. Patients cured from Cushing's disease also made fewer correct substitutions on the Letter-Digit Substitution Test (P = 0.039) and came up with fewer correct patterns on the Figure Fluency Test (P = 0.003) compared with treated NFMA patients. CONCLUSIONS: Cognitive function, reflecting memory and executive functions, is impaired in patients despite long-term cure of Cushing's disease. These observations indicate irreversible effects of previous hypercortisolism on cognitive function and, thus, on the central nervous system. These observations may also be of relevance for patients treated with high-dose exogenous glucocorticoids.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Long-term effects of postnatal GC on the human brain include decreased memory and hippocampal volume (145), decreased cerebellar cortical volume (146), diminished cognitive function (147-149), increased psychopathology, and reduced QOL (148, 150)”
From Congenital Adrenal Hyperplasia Due to Steroid 21-Hydroxylase Deficiency: An Endocrine Society* Clinical Practice Guideline (2018) · cites this paper as [149]
Citations
Cites
Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975) · Journal of Psychiatric Research · doi:10.1016/0022-3956(75)90026-6 · Cited by 88,282
The Hospital Anxiety and Depression Scale
Zigmond, A. S., & Snaith, R. P. (1983) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1983.tb09716.x · Cited by 47,139
Studies of interference in serial verbal reactions
Stroop, J. R. (1935) · Journal of Experimental Psychology · doi:10.1037/h0054651 · Cited by 18,622
L'examen psychologique ; Dans les cas d'ence-phalopathie traumatique (Les problemes)
Rey, A. (1941) · Medical Entomology and Zoology · Cited by 3,319
Neuropsychological assessment.
Cipolotti, L., & Warrington, E. K. (1995) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.58.6.655 · Cited by 3,234
(1995) · Cited by 2,809
SPINHOVEN, P., ORMEL, J., SLOEKERS, P. P. A., KEMPEN, G. I. J. M., SPECKENS, A. E. M., & HEMERT, A. M. V. (1997) · Psychological Medicine · doi:10.1017/s0033291796004382 · Cited by 2,158 · cited 2×
“A total score higher than 13 points on both subscales together is used to characterize subjects as anxious or depressed (32, 33).”
BackgroundMcEwen, B. S. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2007.11.071 · Cited by 1,864 · cited 1×
“pocampus is one of the most sensitive structures in the brain for glucocorticoids and is crucial in cognitive function (37).”
BackgroundPost-Traumatic Stress Disorder
Yehuda, R. (2002) · New England Journal of Medicine · doi:10.1056/nejmra012941 · Cited by 1,134
Starkman, M. N., Gebarski, S. S., Berent, S., & Schteingart, D. E. (1992) · Biological Psychiatry · doi:10.1016/0006-3223(92)90079-f · Cited by 840 · cited 2×
“(11) reported that 27% of the patients with active Cushing’s syndrome fell outside the 95% confidence intervals for normal subject hippocampal formation volume and that hippocampal formation volume and performance on cognitive tests were positively related.”
BackgroundMultilingual Aphasia Examination
(2012) · SpringerReference · doi:10.1007/springerreference_183669 · Cited by 805
Bodnoff, Sr., Humphreys, A., Lehman, J., Diamond, D., Rose, G., & Meaney, M. (1995) · The Journal of Neuroscience · doi:10.1523/jneurosci.15-01-00061.1995 · Cited by 523 · cited 2×
“Transsphnoidal surgery, n (%) 74 (100%) NA NA Postoperative radiotherapy, n (%) 20 (27%) NA NA Duration of remission (yr) 13 (13) NA NA Duration of follow-up (yr) 16 (12) NA NA Hypopituitarism, n (%) Any axis: 43 (58%) GH: 26 (35%) LH/FSH: 19 (26%) TSH: 24 (32%) ADH: 11 (15%) NA NA”
BackgroundChildren's Production on Verbal and Non-Verbal Fluency Tasks
Regard, M., Strauss, E., & Knapp, P. (1982) · Perceptual and Motor Skills · doi:10.2466/pms.1982.55.3.839 · Cited by 513
Colao, A. (1999) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.84.8.2664 · Cited by 450 · cited 1×
“Despite curative treatment, cardiovascular morbidity and mortality remain increased in these patients (1, 2).”
BackgroundBehavioral stress impairs long-term potentiation in rodent hippocampus
Foy, M. R., Stanton, M. E., Levine, S., & Thompson, R. F. (1987) · Behavioral and Neural Biology · doi:10.1016/s0163-1047(87)90664-9 · Cited by 436 · cited 3×
“Transsphnoidal surgery, n (%) 74 (100%) NA NA Postoperative radiotherapy, n (%) 20 (27%) NA NA Duration of remission (yr) 13 (13) NA NA Duration of follow-up (yr) 16 (12) NA NA Hypopituitarism, n (%) Any axis: 43 (58%) GH: 26 (35%) LH/FSH: 19 (26%) TSH: 24 (32%) ADH: 11 (15%) NA NA”
Backgroundvan der Elst, W., van Boxtel, M. P. J., van Breukelen, G. J. P., & Jolles, J. (2006) · Journal of Clinical and Experimental Neuropsychology · doi:10.1080/13803390591004428 · Cited by 386 · cited 7×
“Patients cured from Cushing’s disease also made fewer correct substitutions on the Letter-Digit Substitution Test (P=0.039) and came up with fewer correct patterns on the Figure Fluency Test (P=0.003) compared with treated NFMA patients.”
MethodInfluentialMultiplicity in randomised trials I: endpoints and treatments
Schulz, K. F., & Grimes, D. A. (2005) · The Lancet · doi:10.1016/s0140-6736(05)66461-6 · Cited by 366
Multiplicity in randomised trials II: subgroup and interim analyses
Schulz, K. F., & Grimes, D. A. (2005) · The Lancet · doi:10.1016/s0140-6736(05)66516-6 · Cited by 357 · cited 3×
“This is also reflected in the Lancet papers by Schulz and Grimes (40, 41), who advocate a restrictive approach toward adjustments for multiple comparisons.”
BackgroundResultBiermasz, N. R., van Thiel, S. W., Pereira, A. M., Hoftijzer, H. C., van Hemert, A. M., Smit, J. W. A., Romijn, J. A., & Roelfsema, F. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0669 · Cited by 254 · cited 1×
“In previous studies, we used similarly selected controls and compared the responses of these matched controls with those obtained from published Dutch control populations for several questionnaires (including HADS, Nottingham Health Profile, Multidimensional Fatigue Index, and Short Form) (3, 42, 43).”
ResultSelf-citationQuality of Life in Patients after Long-Term Biochemical Cure of Cushing’s Disease
van Aken, M. O., Pereira, A. M., Biermasz, N. R., van Thiel, S. W., Hoftijzer, H. C., Smit, J. W. A., Roelfsema, F., Lamberts, S. W. J., & Romijn, J. A. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1375 · Cited by 253
Self-citationDekkers, O. M., Biermasz, N. R., Pereira, A. M., Roelfsema, F., van Aken, M. O., Voormolen, J. H. C., & Romijn, J. A. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-2112 · Cited by 223 · cited 1×
“Despite curative treatment, cardiovascular morbidity and mortality remain increased in these patients (1, 2).”
BackgroundSelf-citationEffects of Glucocorticoids on Mood, Memory, and the Hippocampus: Treatment and Preventive Therapy
Brown, E. S. (2009) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.04981.x · Cited by 214
Elevated Cortisol Levels in Cushing’s Disease Are Associated With Cognitive Decrements
Starkman, M. N., Giordani, B., Berent, S., Schork, M. A., & Schteingart, D. E. (2001) · Psychosomatic Medicine · doi:10.1097/00006842-200111000-00018 · Cited by 206
Glucocorticoids: Mood, Memory, and Mechanisms
Wolkowitz, O. M., Burke, H., Epel, E. S., & Reus, V. I. (2009) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.04980.x · Cited by 181 · cited 1×
“In addition, the results might also be of relevance for patients with chronically increased glucocorticoid levels in conditions like depression (38, 39).”
BackgroundImprovement in learning associated with increase in hippocampal formation volume
Starkman, M. N., Giordani, B., Gebarski, S. S., & SCHTEINGART, D. E. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(02)01750-x · Cited by 173
Cognitive decline in patients with Cushing's syndrome
FORGET, H., LACROIX, A., SOMMA, M., & COHEN, H. (2000) · Journal of the International Neuropsychological Society · doi:10.1017/s1355617700611037 · Cited by 161
The brain as a target for adrenocortical steroids: Cognitive implications
Martignoni, E., Costa, A. C., Sinforiani, E., Liuzzi, A., Chiodini, P. G., Mauri, M. F., Bono, G. G., & Nappi, G. (1992) · Psychoneuroendocrinology · doi:10.1016/0306-4530(92)90040-e · Cited by 157
Persistent cognitive impairment following surgical treatment of Cushing's syndrome
Forget, H., Lacroix, A., & Cohen, H. (2002) · Psychoneuroendocrinology · doi:10.1016/s0306-4530(01)00059-2 · Cited by 151 · cited 5×
“Fur- Chapter 586 Table 1 Clinical characteristics of patients cured from Cushing’s disease and matched controls Cushing’s disease (n=74) Matched controls (n=74) P-value Gender (male/female) 13/61 13/61 1.00 Age (yrs) 52 ± 13 52 ± 13 0.26 Education (n) Low (29) Average (19) High (26) Low (28) Average (22) High (24) 0.2…”
BackgroundResultInfluentialMemory impairment in Cushing's disease
Mauri, M., Sinforiani, E., Bono, G., Vignati, F., Berselli, M. E., Attanasio, R., & Nappi, G. (2009) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1993.tb04075.x · Cited by 151 · cited 3×
“Romijn Journal of Clinical Endocrinology & Metabolism 2010; 95(6):2699-714 Tiemensma hfd 5:Layout 1 23-01-2012 16:32 Pagina 79”
BackgroundMethodNeuropsychological Deficits in Cushing??s Syndrome
WHELAN, T. B., SCHTEINGART, D. E., STARKMAN, M. N., & SMITH, A. (1980) · The Journal of Nervous and Mental Disease · doi:10.1097/00005053-198012000-00008 · Cited by 128
Quality of Life Is Decreased after Treatment for Nonfunctioning Pituitary Macroadenoma
Dekkers, O. M., van der Klaauw, A. A., Pereira, A. M., Biermasz, N. R., Honkoop, P. J., Roelfsema, F., Smit, J. W. A., & Romijn, J. A. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0003 · Cited by 124 · cited 1×
“In previous studies, we used similarly selected controls and compared the responses of these matched controls with those obtained from published Dutch control populations for several questionnaires (including HADS, Nottingham Health Profile, Multidimensional Fatigue Index, and Short Form) (3, 42, 43).”
ResultSelf-citationCentral nervous system effects of natural and synthetic glucocorticoids
Fietta, P., Fietta, P., & Delsante, G. (2009) · Psychiatry and Clinical Neurosciences · doi:10.1111/j.1440-1819.2009.02005.x · Cited by 111 · cited 4×
“Coping strategies in pituitary patients 87 Table 2 Clinical characteristics of the patients treated for NFMA and matched controls NFMA (n=54) Matched controls (n=54) P-value Gender (male/female) 30/24 30/24 1.00 Age (yrs) 61± 11 59 ± 11 0.06 Education (n) Low (18) Average (21) High (15) Low (21) Average (15) High (18)…”
InfluentialNeuropsychological abnormalities in patients with pituitary tumours
Grattan‐Smith, P. J., Morris, J. G., Shores, E. A., Batchelor, J., & Sparks, R. S. (1992) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1992.tb05500.x · Cited by 100
Peace, Orme, Padayatty, Godfrey, & Belchetz (1998) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1998.00543.x · Cited by 91
Cognitive Function and Cerebral Assessment in Patients Who Have Cushing's Syndrome
Bourdeau, I., Bard, C., Forget, H., Boulanger, Y., Cohen, H., & Lacroix, A. (2005) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2005.01.016 · Cited by 87
Chronic glucocorticoid hypersecretion in Cushing’s syndrome exacerbates cognitive aging
Michaud, K., Forget, H., & Cohen, H. (2009) · Brain and Cognition · doi:10.1016/j.bandc.2009.02.013 · Cited by 82
HOOK, J. N., GIORDANI, B., SCHTEINGART, D. E., GUIRE, K., GILES, J., RYAN, K., GEBARSKI, S. S., LANGENECKER, S. A., & STARKMAN, M. N. (2007) · Journal of the International Neuropsychological Society · doi:10.1017/s1355617707070051 · Cited by 80 · cited 2×
“This indicates that some but not all of the effects of previous glucocorticoid excess are reversible (20).”
BackgroundCognitive dysfunction in patients treated for pituitary tumours
Peace, K. A., Orme, S. M., Thompson, A. R., Padayatty, S., Ellis, A. W., & Belchetz, P. E. (1997) · Journal of Clinical and Experimental Neuropsychology · doi:10.1080/01688639708403831 · Cited by 72
Cognitive Function in Patients with Cushing Syndrome: A Longitudinal Perspective
Dorn, L. D., & Cerrone, P. (2000) · Clinical Nursing Research · doi:10.1177/10547730022158672 · Cited by 46 · cited 6×
“There was also a negative association between some IQ subscales and duration of disease (18).”
BackgroundResultInfluentialA clinical profile of memory impairment in humans due to endogenous glucocorticoid excess
León‐Carrión, J., Atutxa, A. M., Mangas, M. A., Soto‐Moreno, A., Pumar, A., Leon‐Justel, A., Martín‐Rodriguez, J. F., Venegas, E., Domínguez‐Morales, M. R., & Leal‐Cerro, A. (2009) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2008.03355.x · Cited by 45
Research works printed but not linked: 5
- Wechsler, 1945, Wechsler Memory Scale
- Rey, 1958, L’examin Clinique en Psyhcologie
- Rey, 1941, L’examen psychologique dans les cas d’encephalopathie traumatique, Arch Psychol, 28, 286
- Reitan, 1956, Trail making test: manual for administration, scoring, and interpretation
- Luteijn, 1983, Manual Groninger Intelligence Test
Cited by
Speiser, P. W., Azziz, R., Baskin, L. S., Ghizzoni, L., Hensle, T. W., Merke, D. P., Meyer-Bahlburg, H. F. L., Miller, W. L., Montori, V. M., Oberfield, S. E., et al. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2631 · Cited by 1,468
Treatment of Cushing's syndrome: an Endocrine Society clinical practice guideline
Nieman, L. K., Biller, B. M. K., Findling, J. W., Murad, M. H., Newell-Price, J., Savage, M. O., & Tabarin, A. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-1818 · Cited by 1,270
“Deficits also occur in attention, visuospatial abilities, and working memory (185).”
BackgroundResultSpeiser, P. W., Arlt, W., Auchus, R. J., Baskin, L. S., Conway, G. S., Merke, D. P., Meyer-Bahlburg, H. F. L., Miller, W. L., Murad, M. H., Oberfield, S. E., et al. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-01865 · Cited by 1,234
The Treatment of Cushing's Disease
Pivonello, R., De Leo, M., Cozzolino, A., & Colao, A. (2015) · Endocrine Reviews · doi:10.1210/er.2013-1048 · Cited by 465
Feelders, R. A., Pulgar, S. J., Kempel, A., & Pereira, A. M. (2012) · European Journal of Endocrinology · doi:10.1530/eje-11-1095 · Cited by 256
Self-citation
Metadata
- Authors
- Tiemensma, J., Kokshoorn, N. E., Biermasz, N. R., Keijser, B.-J. S. A., Wassenaar, M. J. E., Middelkoop, H. A. M., Pereira, A. M., & Romijn, J. A.
- Affiliations
- Leiden University Medical Center (NL)
- ORCID
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2010-06-01
- Volume
- 95
- Issue
- 6
- Pages
- 2699-2714
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2001003028
- Cited by
- 159
- References
- 41
- Citations by year
- 2026: 2 · 2025: 7 · 2024: 9 · 2023: 6 · 2022: 8 · 2021: 8 · 2020: 9 · 2019: 12 · 2018: 14 · 2017: 5 · 2016: 15 · 2015: 18 · 2014: 10 · 2013: 12 · 2012: 9
- FWCI
- 8.69
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Pure Amsterdam UMC (publishedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Leiden Repository (Leiden University) (submittedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pituitary Gland Disorders and Treatments
- Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
- Health Sciences › Medicine › Oncology › Cancer-related cognitive impairment studies
- Keywords
- Cushing's disease, hypercortisolism, cognitive impairment, memory impairment, executive function, long-term cure, non-functioning pituitary macroadenoma, verbal learning, visuospatial ability
- MeSH terms
- Adult, Aged, Anxiety, Cognition Disorders, Depression, Female, Humans, Male, Memory, Memory, Short-Term, Middle Aged, Neuropsychological Tests, Pituitary Function Tests, Psychiatric Status Rating Scales, Wechsler Scales, Treatment Outcome, Survivors, Pituitary ACTH Hypersecretion, ACTH-Secreting Pituitary Adenoma
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.